UNITY Biotechnology Reports Granting of New Employment Inducement Awards
July 28 2021 - 8:00AM
UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology
company developing therapeutics to slow, halt, or reverse diseases
of aging, today announced that from July 13, 2021, through July 27,
2021, the Compensation Committee of the Board of Directors (the
“Board”) granted 3 new employees stock-based awards covering an
aggregate of 41,900 shares of UNITY common stock, including options
to purchase an aggregate of 41,900 shares of UNITY common stock.
The stock-based awards were granted pursuant to the UNITY 2020
Employment Inducement Incentive Plan, as amended, which was
approved by the Board in March 2020 to provide for grants to newly
hired employees as a material inducement for them to commence
employment with UNITY in accordance with Nasdaq Stock Market Rule
5635(c)(4).
About UNITYUNITY is developing a new class of
therapeutics to slow, halt or reverse diseases of aging. UNITY’s
current focus is on creating medicines to selectively eliminate or
modulate senescent cells and thereby provide transformative benefit
in age-related ophthalmologic and neurologic diseases.
More information is available
at www.unitybiotechnology.com or follow us
on Twitter and LinkedIn.
Media
Canale Communications
Jason Spark
Jason.spark@canalecomm.com
UNITY Biotechnology (NASDAQ:UBX)
Historical Stock Chart
From Aug 2024 to Sep 2024
UNITY Biotechnology (NASDAQ:UBX)
Historical Stock Chart
From Sep 2023 to Sep 2024